TestBank
,
, Chapter1:DrugDefinitions, Standards,andInformation Sources Test Bank
, , , , , , , , ,
MULTIPLECHOICE ,
1. What is the name under which a drug is listed bythe U.S. Food and Drug Administration
, , , , , , , , , , , , , , , ,
(FDA)?
,
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C ,
The official name is the name under which a drug is listed by the FDA. The brand name, or
, , , , , , , , , , , , , , , , , ,
trademark, is the name given to a drug by its manufacturer. The nonproprietary, or generic,
, , , , , , , , , , , , , , ,
name is provided by the U.S. Adopted Names Council.
, , , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 1 OBJ: 2TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
2. Whichsource contains information specific to nutritional supplements?
, , , , , , ,
a. USP Dictionary of USAN &International Drug Names , , , , , , ,
b. Natural Medicines Comprehensive Database , , ,
c. United States Pharmacopoeia/National Formulary (USP NF) , , , , ,
d. Drug Interaction Facts , ,
ANS: C ,
United States Pharmacopoeia/National Formulary contains information specific to nutritional
, , , , , , , ,
supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug
, , , , , , , , , , , , , ,
names, pronunciation guide, and possible future FDA approved drugs; it does not include
, , , , , , , , , , , , ,
nutritional supplements. Natural Medicines Comprehensive Database contains evidence based
, , , , , , , , ,
information on herbal medicines and herbal combination products; it does not include information
, , , , , , , , , , , , ,
specific to nutritional supplements. Drug Interaction Facts contains comprehensive information
, , , , , , , , , ,
on drug interaction facts; it does not include nutritional supplements.
, , , , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 2 OBJ: 4TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
3. What is the most comprehensive reference available to research a drug interaction?
, , , , , , , , , , ,
a. Drug Facts and Comparisons , , ,
b. Drug Interaction Facts , ,
c. Handbook on Injectable Drugs , , ,
d. Martindale—TheComplete Drug Reference , , ,
ANS: B ,
First published in 1983, Drug Interaction Facts is the most comprehensive book available
, , , , , , , , , , , ,
ondrug interactions. In addition to monographs listing various aspects of drug interactions, this
, , , , , , , , , , , , ,
information is reviewed and updated by an internationally renowned group of physicians
, , , , , , , , , , , ,
andpharmacists with clinical and scientific expertise.
, , , , , ,
DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: 3TOP:
, , , , , , , ,
, Nursing Process Step: Assessment , , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
4. The physician has written an order for a drug with which the nurse is unfamiliar. Which section of
, , , , , , , , , , , , , , , , ,
the Physicians’ Desk Reference (PDR) is most helpful to get information about this drug?
, , , , , , , , , , , , , ,
a. Manufacturer’ssection ,
b. Brand and Generic Name section , , , ,
c. Product Categorysection , ,
d. ProductInformationsection , ,
ANS: B
, ,
DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: 4TOP:
, , , , , , , ,
Nursing Process Step: Planning , , ,
MSC: NCLEXClient NeedsCategory: Physiological Integrity
, , , , , ,
5. Which online drug reference makes available to health care providers and the public a
, , , , , , , , , , , , ,
standard, comprehensive, uptodate look up and downloadable resource about medicines?
, , , , , , , , , , , ,
a. American Drug Index , ,
b. American Hospital Formulary , ,
c. DailyMed
d. Physicians’ DeskReference (PDR) , , ,
ANS: C ,
DailyMed makes available to health care providers and the public a standard, comprehensive, up
, , , , , , , , , , , , ,
to date look up and downloadable resource about medicines. The American Drug Index is not
, , , , , , , , , , , , , , ,
appropriate for patient use. The American Hospital Formulary is not appropriate for patient use.
, , , , , , , , , , , , , ,
The PDR is not appropriate for patient use.
, , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 5TOP: Nursing
, , , , , , , , ,
Process Step: Implementation
, , ,
MSC: NCLEXClient NeedsCategory: Physiological Integrity
, , , , , ,
6. Whichlegislation authorizes the FDA to determine the safety of a drug before its marketing?
, , , , , , , , , , , , , ,
a. Federal Food, Drug, and Cosmetic Act (1938) , , , , , ,
b. Durham Humphrey Amendment (1952) , , ,
c. Controlled Substances Act (1970) , , ,
d. Kefauver Harris Drug Amendment (1962) , , , ,
ANS: A ,
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety of
, , , , , , , , , , , , , , , ,
all drugs before marketing. Later amendments and acts helped tighten FDA control and ensure
, , , , , , , , , , , , , ,
drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be used
, , , , , , , , , , , , , , ,
safely without medical supervision and restricts their sale to prescription by a licensed
, , , , , , , , , , , , ,
practitioner. The Controlled Substances Act addresses onlycontrolled substances and their
, , , , , , , , , , ,
categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug
, , , , , , , , , , , ,
safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products
, , , , , , , , , , , , , , ,
before marketing them.
, , ,
DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 8TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
7. Meperidine(Demerol) is a narcotic with a high potential for physical and psychological
, , , , , , , , , , , ,
, dependency. Under which classification does this drug fall? , , , , , , ,
a. I
b. II
c. III
d. IV
ANS: B ,
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to severe
, , , , , , , , , , , , , , , , , ,
psychological and physical dependence. Schedule Idrugs have high potential forabuse and no
, , , , , , , , , , , , , ,
recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to low to
, , , , , , , , , , , , , , , , ,
moderate physical dependence or high psychological dependence. Schedule IV drugs have low
, , , , , , , , , , , ,
potential for abuse. Use may lead to limited physical or psychological dependence.
, , , , , , , , , , , ,
DIF: Cognitive Level: Comprehension REF: p. 4 |p. 5 OBJ: 7TOP:
, , , , , , , , , , ,
Nursing Process Step: Assessment
, , , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
8. What would the FDA do to expedite drug development and approval for an outbreak of
, , , , , , , , , , , , , ,
smallpox, for which there is no known treatment?
, , , , , , , ,
a. List smallpox as a health orphan disease.
, , , , , ,
b. Omit the preclinical research phase. , , , ,
c. Extend the clinical research phase. , , , ,
d. Fast track the investigational drug.
, , , ,
ANS: D ,
Once the Investigational New Drug Application has been approved, the drug can receive highest
, , , , , , , , , , , , ,
priority within the agency, which is called fast tracking. A smallpox outbreak would become a
, , , , , , , , , , , , , , ,
priority concern in the world. Orphan diseases are not researched in a priority manner. Preclinical
, , , , , , , , , , , , , , ,
research is not omitted. Extending any phase of the research would mean a longer time to develop a
, , , , , , , , , , , , , , , , , ,
vaccine. The FDA must ensure that all phases of the preclinical and clinical research phase have
, , , , , , , , , , , , , , , ,
been completed in a safe manner.
, , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 7 OBJ: 8TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
9. Whichstatement is true about over the counter (OTC) drugs?
, , , , , , , , ,
a. They are not listed in the USP NF. , , , , , , ,
b. A prescription from a health care provider is needed.
, , , , , , , ,
c. Theyare sold without a prescription. , , , , ,
d. They are known only by their brand names. , , , , , , ,
ANS: C ,
OTC medications do not require a prescription. A variety of names, both generic and trade, can be
, , , , , , , , , , , , , , , ,
used for individual drugs sold OTC. OTC drugs are listed in the USP NF. Prescription drugs
, , , , , , , , , , , , , , , ,
require an order by a health professional who is licensed to prescribe, such as a physician, nurse
, , , , , , , , , , , , , , , , ,
practitioner, physician assistant, or dentist.
, , , , ,
DIF: Cognitive Level: Comprehension REF: p. 2 OBJ: 2TOP: Nursing
, , , , , , , , ,
Process Step: Planning
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
10. Whichis the most authoritative reference for medications that are injected?
, , , , , , , , , ,
,
, Chapter1:DrugDefinitions, Standards,andInformation Sources Test Bank
, , , , , , , , ,
MULTIPLECHOICE ,
1. What is the name under which a drug is listed bythe U.S. Food and Drug Administration
, , , , , , , , , , , , , , , ,
(FDA)?
,
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C ,
The official name is the name under which a drug is listed by the FDA. The brand name, or
, , , , , , , , , , , , , , , , , ,
trademark, is the name given to a drug by its manufacturer. The nonproprietary, or generic,
, , , , , , , , , , , , , , ,
name is provided by the U.S. Adopted Names Council.
, , , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 1 OBJ: 2TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
2. Whichsource contains information specific to nutritional supplements?
, , , , , , ,
a. USP Dictionary of USAN &International Drug Names , , , , , , ,
b. Natural Medicines Comprehensive Database , , ,
c. United States Pharmacopoeia/National Formulary (USP NF) , , , , ,
d. Drug Interaction Facts , ,
ANS: C ,
United States Pharmacopoeia/National Formulary contains information specific to nutritional
, , , , , , , ,
supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug
, , , , , , , , , , , , , ,
names, pronunciation guide, and possible future FDA approved drugs; it does not include
, , , , , , , , , , , , ,
nutritional supplements. Natural Medicines Comprehensive Database contains evidence based
, , , , , , , , ,
information on herbal medicines and herbal combination products; it does not include information
, , , , , , , , , , , , ,
specific to nutritional supplements. Drug Interaction Facts contains comprehensive information
, , , , , , , , , ,
on drug interaction facts; it does not include nutritional supplements.
, , , , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 2 OBJ: 4TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
3. What is the most comprehensive reference available to research a drug interaction?
, , , , , , , , , , ,
a. Drug Facts and Comparisons , , ,
b. Drug Interaction Facts , ,
c. Handbook on Injectable Drugs , , ,
d. Martindale—TheComplete Drug Reference , , ,
ANS: B ,
First published in 1983, Drug Interaction Facts is the most comprehensive book available
, , , , , , , , , , , ,
ondrug interactions. In addition to monographs listing various aspects of drug interactions, this
, , , , , , , , , , , , ,
information is reviewed and updated by an internationally renowned group of physicians
, , , , , , , , , , , ,
andpharmacists with clinical and scientific expertise.
, , , , , ,
DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: 3TOP:
, , , , , , , ,
, Nursing Process Step: Assessment , , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
4. The physician has written an order for a drug with which the nurse is unfamiliar. Which section of
, , , , , , , , , , , , , , , , ,
the Physicians’ Desk Reference (PDR) is most helpful to get information about this drug?
, , , , , , , , , , , , , ,
a. Manufacturer’ssection ,
b. Brand and Generic Name section , , , ,
c. Product Categorysection , ,
d. ProductInformationsection , ,
ANS: B
, ,
DIF: Cognitive Level: Comprehension REF: p. 3 OBJ: 4TOP:
, , , , , , , ,
Nursing Process Step: Planning , , ,
MSC: NCLEXClient NeedsCategory: Physiological Integrity
, , , , , ,
5. Which online drug reference makes available to health care providers and the public a
, , , , , , , , , , , , ,
standard, comprehensive, uptodate look up and downloadable resource about medicines?
, , , , , , , , , , , ,
a. American Drug Index , ,
b. American Hospital Formulary , ,
c. DailyMed
d. Physicians’ DeskReference (PDR) , , ,
ANS: C ,
DailyMed makes available to health care providers and the public a standard, comprehensive, up
, , , , , , , , , , , , ,
to date look up and downloadable resource about medicines. The American Drug Index is not
, , , , , , , , , , , , , , ,
appropriate for patient use. The American Hospital Formulary is not appropriate for patient use.
, , , , , , , , , , , , , ,
The PDR is not appropriate for patient use.
, , , , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 5TOP: Nursing
, , , , , , , , ,
Process Step: Implementation
, , ,
MSC: NCLEXClient NeedsCategory: Physiological Integrity
, , , , , ,
6. Whichlegislation authorizes the FDA to determine the safety of a drug before its marketing?
, , , , , , , , , , , , , ,
a. Federal Food, Drug, and Cosmetic Act (1938) , , , , , ,
b. Durham Humphrey Amendment (1952) , , ,
c. Controlled Substances Act (1970) , , ,
d. Kefauver Harris Drug Amendment (1962) , , , ,
ANS: A ,
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety of
, , , , , , , , , , , , , , , ,
all drugs before marketing. Later amendments and acts helped tighten FDA control and ensure
, , , , , , , , , , , , , ,
drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be used
, , , , , , , , , , , , , , ,
safely without medical supervision and restricts their sale to prescription by a licensed
, , , , , , , , , , , , ,
practitioner. The Controlled Substances Act addresses onlycontrolled substances and their
, , , , , , , , , , ,
categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater drug
, , , , , , , , , , , ,
safety. Drug manufacturers are required to prove to the FDA the effectiveness of their products
, , , , , , , , , , , , , , ,
before marketing them.
, , ,
DIF: Cognitive Level: Knowledge REF: p. 4 OBJ: 8TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
7. Meperidine(Demerol) is a narcotic with a high potential for physical and psychological
, , , , , , , , , , , ,
, dependency. Under which classification does this drug fall? , , , , , , ,
a. I
b. II
c. III
d. IV
ANS: B ,
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to severe
, , , , , , , , , , , , , , , , , ,
psychological and physical dependence. Schedule Idrugs have high potential forabuse and no
, , , , , , , , , , , , , ,
recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to low to
, , , , , , , , , , , , , , , , ,
moderate physical dependence or high psychological dependence. Schedule IV drugs have low
, , , , , , , , , , , ,
potential for abuse. Use may lead to limited physical or psychological dependence.
, , , , , , , , , , , ,
DIF: Cognitive Level: Comprehension REF: p. 4 |p. 5 OBJ: 7TOP:
, , , , , , , , , , ,
Nursing Process Step: Assessment
, , , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
8. What would the FDA do to expedite drug development and approval for an outbreak of
, , , , , , , , , , , , , ,
smallpox, for which there is no known treatment?
, , , , , , , ,
a. List smallpox as a health orphan disease.
, , , , , ,
b. Omit the preclinical research phase. , , , ,
c. Extend the clinical research phase. , , , ,
d. Fast track the investigational drug.
, , , ,
ANS: D ,
Once the Investigational New Drug Application has been approved, the drug can receive highest
, , , , , , , , , , , , ,
priority within the agency, which is called fast tracking. A smallpox outbreak would become a
, , , , , , , , , , , , , , ,
priority concern in the world. Orphan diseases are not researched in a priority manner. Preclinical
, , , , , , , , , , , , , , ,
research is not omitted. Extending any phase of the research would mean a longer time to develop a
, , , , , , , , , , , , , , , , , ,
vaccine. The FDA must ensure that all phases of the preclinical and clinical research phase have
, , , , , , , , , , , , , , , ,
been completed in a safe manner.
, , , , , ,
DIF: Cognitive Level: Knowledge REF: p. 7 OBJ: 8TOP: Nursing
, , , , , , , , ,
Process Step: Assessment
, , ,
MSC: NCLEX Client Needs Category: Safe, Effective CareEnvironment
, , , , , , , ,
9. Whichstatement is true about over the counter (OTC) drugs?
, , , , , , , , ,
a. They are not listed in the USP NF. , , , , , , ,
b. A prescription from a health care provider is needed.
, , , , , , , ,
c. Theyare sold without a prescription. , , , , ,
d. They are known only by their brand names. , , , , , , ,
ANS: C ,
OTC medications do not require a prescription. A variety of names, both generic and trade, can be
, , , , , , , , , , , , , , , ,
used for individual drugs sold OTC. OTC drugs are listed in the USP NF. Prescription drugs
, , , , , , , , , , , , , , , ,
require an order by a health professional who is licensed to prescribe, such as a physician, nurse
, , , , , , , , , , , , , , , , ,
practitioner, physician assistant, or dentist.
, , , , ,
DIF: Cognitive Level: Comprehension REF: p. 2 OBJ: 2TOP: Nursing
, , , , , , , , ,
Process Step: Planning
, , ,
MSC: NCLEXClient Needs Category: Physiological Integrity
, , , , , ,
10. Whichis the most authoritative reference for medications that are injected?
, , , , , , , , , ,
